Abstracts

Peripheral Neuropathy at First-Line Failure and on Second Line in Sub-Saharan Africa

Background: Sensory peripheral neuropathy (PN) remains a common complication in HIV-positive patients despite effective anti-retroviral therapy (ART). Data on PN during second-line cART is scarce. Methods: We assessed PN using the ACTG Brief Peripheral Neuropathy Screen tool in patients failing first-line ART and for 96 weeks following a switch to PI-based second-line ART in the…

Prevalence of and Risk Factors for Peripheral Neuropathy in Rakai, Uganda

Background: Peripheral neuropathy (PN) is a common and potentially debilitating neurologic complication of HIV infection. Systematic studies to identify the prevalence of and risk factors for PN in sub-Saharan Africa are lacking. Methods: A sample of participants in the Rakai Community Cohort Study underwent detailed neurological evaluation including assessment of demographic characteristics, subjective PN symptoms,…

Predictors of Cognitive Performance Among HIV-Infected Patients in East Africa

Background: Cognitive impairment remains a frequent complication of HIV despite access to antiretroviral therapy. Few data exist regarding risk factors in resource-limited settings. Methods: The African Cohort Study (AFRICOS) aims to longitudinally assess the impact of clinical practices, biological factors and socio-behavioral issues on HIV infection and disease progression in an African context. All enrollees…

Mitochondrial DNA Haplogroups and CSF Neuroinflammation in the CHARTER Cohort

Background: Neurocognitive impairment (NCI) remains an important complication in the combination antiretroviral therapy (CART) era, and is associated with neuroinflammation in cerebrospinal fluid (CSF). Mitochondrial DNA (mtDNA) haplogroups are ancestry-related patterns of single-nucleotide polymorphisms that are associated with differential mitochondrial function in model systems, neurodegenerative diseases in HIV-uninfected populations, and HIV- and CART-associated outcomes in…

Iron-Regulatory Genes Are Associated With Neuroimaging Traits in HIV Infection

Background: HIV-Associated Neurocognitive Disorders (HAND) remain highly prevalent, despite viral suppression with combination antiretroviral therapy. Structural and metabolic changes in the brain may occur early in HIV-infection and represent important endophenotypes of HAND. Since brain iron dysregulation is a common feature of neurodegenerative disorders and iron is linked to immune regulation, we hypothesized that iron-regulatory-gene…

Synergistic Effects of MBL2/APP Polymorphisms on Neurocognitive Impairment in CHARTER

Background: Mannose binding lectin (MBL), coded by MBL2, recognizes mannose laden glycans on HIV-1 gp120 and activates complement for virus opsonization. Also, via its cysteine rich region, MBL interacts with amyloid beta (coded by APP) presumably for clearing it by complement mediated lyses. We hypothesized that the synergistic effects of polymorphisms in APP promoter (rs364048)…

Bridging Genetics, Histopathology, and Neurocognition in the Context of HAND

Background: It is unclear which histopathological features of HIV underlie the symptoms of HIV-associated neurocognitive disorders (HAND). Host-genetic association studies have implicated a variety of risk alleles for HAND, but findings have been difficult to replicate due largely to the fact that the neuropsychological impairments common in HAND are heterogeneous across patients. Instead, focusing on…

Relative Risk and Factors Associated With Progression to Symptomatic HAND

Background: HIV-associated neurocognitive disorders (HAND) remain prevalent and recent work by Grant and colleagues (2014) demonstrated that asymptomatic neurocognitive impairment (ANI) is associated with a 2-5 risk for the development of symptomatic HAND (mild neurocognitive impairment [MND] or HIV-associated dementia [HAD]) in persons followed in CHARTER. We were interested in replicating and extending these results…

Monocytes Activation Characterizes Immune Failure but Not Cognitive Impairment on ART

Background: Neurocognitive impairment (NCI) in HIV+ patients can occur despite effective ART and has been linked to increased CD16-bearing monocytes in circulation. We evaluated monocytes (M/M) phenotypes and activation markers in HIV+ patients under ART, aiming to define the role of innate immune activation on CD4+ T cell recovery and NCI. Methods: Cross sectional study:…